Search hospitals > California > Stanford
Stanford University
Claim this profileStanford, California 94305
Global Leader in Type 1 Diabetes
Global Leader in Diabetes
Conducts research for Depression
Conducts research for Cancer
Conducts research for Lymphoma
1398 reported clinical trials
206 medical researchers
Summary
Stanford University is a medical facility located in Stanford, California. This center is recognized for care of Type 1 Diabetes, Diabetes, Depression, Cancer, Lymphoma and other specialties. Stanford University is involved with conducting 1,398 clinical trials across 1,422 conditions. There are 206 research doctors associated with this hospital, such as Robert Lowsky, MD, Christopher Chen, John Day, MD, PhD, and Andrei Iagaru, MD.Area of expertise
1Type 1 Diabetes
Global LeadermIAA positive
IA-2A positive
ICA positive
2Diabetes
Global LeaderGAD65A positive
mIAA positive
IA-2A positive
Top PIs
Robert Lowsky, MDStanford University1 year of reported clinical research
Studies Acute Lymphoblastic Leukemia
Studies Lymphoblastic Leukemia-Lymphoma
13 reported clinical trials
21 drugs studied
Christopher ChenStanford Cancer Institute1 year of reported clinical research
Studies Colorectal Cancer
Studies Cancer
13 reported clinical trials
19 drugs studied
John Day, MD, PhDStanford University4 years of reported clinical research
Studies Atrophy
Studies Muscular Atrophy
11 reported clinical trials
10 drugs studied
Andrei Iagaru, MDStanford University, School of Medicine7 years of reported clinical research
Studies Adenocarcinoma
Studies Prostate Cancer
14 reported clinical trials
20 drugs studied
Clinical Trials running at Stanford University
Depression
Tumors
Ovarian Cancer
Atrial Fibrillation
Glioblastoma
Non-Small Cell Lung Cancer
Fallopian Tube Cancer
Chronic Kidney Disease
Fuchs' Dystrophy
Patent Ductus Arteriosus
rTMS
for Treatment-Resistant Depression
This trial is testing a magnetic brain stimulation treatment for people with depression who don't respond to standard medications. The treatment uses magnetic pulses to target brain areas involved in mood regulation, aiming to improve symptoms. The method has been studied for its effectiveness in treating major depression.
Recruiting2 awards Phase 318 criteria
Sleep Therapy
for Depression and Anxiety
This project is the second phase of a two-phased project investigating the impact of a proven sleep intervention, Cognitive Behavioral Therapy for Insomnia (CBT-I) on engagement of the emotion regulation brain network as a putative mechanistic target.
Recruiting1 award N/A3 criteria
Cognitive Behavioral Therapy
for Insomnia to Treat Depression
Several lines of evidence suggest that unhealthy sleep patterns contribute to depressive symptoms through disruption of brain networks that regulate emotional functions. However, we do not yet know to what degree the emotion regulation brain network is modified by the restoration of sleep, or whether the degree to which a sleep intervention modifies these neural targets mediates reductions in other depressive symptoms including suicidality. The overall aim is to test the efficacy of an established sleep intervention (Cognitive Behavioral Therapy for Insomnia (CBT-I)) in reducing depressive symptoms through improving emotion regulation brain function in individuals with elevated depressive symptoms and clinically meaningful sleep disturbance. In this study, we will assess feasibility of recruitment and retention as well as target engagement. Target engagement is defined as the treatment effect on increasing mPFC-amygala connectivity, and/or decreasing amygdala reactivity during emotion reactivity and regulation paradigms. Participants will be 70 adults experiencing at least moderate sleep disturbances and who also have elevated anxious and/or depressive symptoms. Emotion distress and sleep disruption will be assessed prior to, and weekly while receiving six Cognitive Behavioral Therapy for Insomnia (CBT-I) across a period of 8 weeks. CBT-I improves sleep patterns through a combination of sleep restriction, stimulus control, mindfulness training, cognitive therapy targeting dysfunctional beliefs about sleep, and sleep hygiene education. Using fMRI scanning, emotion regulation network neural targets will be assayed prior to and following completion of CBT-I treatment.
Recruiting1 award N/A6 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Stanford University?
Stanford University is a medical facility located in Stanford, California. This center is recognized for care of Type 1 Diabetes, Diabetes, Depression, Cancer, Lymphoma and other specialties. Stanford University is involved with conducting 1,398 clinical trials across 1,422 conditions. There are 206 research doctors associated with this hospital, such as Robert Lowsky, MD, Christopher Chen, John Day, MD, PhD, and Andrei Iagaru, MD.
Where is Stanford University located?
Stanford Hospital is located at 300 Pasteur Drive, Stanford, California. It operates 24/7, ensuring round-the-clock care. Parking is available at the Pasteur Visitor Garage and the Roth Way Garage.
Who should I call to ask about financial aid or insurance network?
For financial assistance at Stanford University Hospital, contact the Financial Counseling department at 844-498-2900 and select option 2. For insurance-related inquiries, reach out to the University HR Service Team at 877-905-2985.
What insurance does Stanford University accept?
Stanford University Hospital accepts a wide range of insurance plans, such as employer-provided, Covered California, Individual-Family Plans, CalPERS, Medi-Cal, Medicare, TRICARE and TriWest, and Workers Comp. It's crucial to confirm the hospital's in-network status for your specific plan by consulting their website or directly contacting your insurance provider. Additionally, Stanford Health Care advises consulting with their social workers and medical team for assistance in choosing a plan that includes behavioral health services.
What awards or recognition has Stanford University received?
Stanford University Hospital, located in Stanford, California, is renowned for its groundbreaking research and exceptional patient care. In 2023, it celebrated the achievement of six researchers who were honored with High-Risk, High-Reward Research program grants by the National Institutes of Health (NIH) for their pioneering work in fields like cancer immunotherapies and synthetic biology. The hospital has also earned prestigious awards, including the Vizient Quality Leadership Award 2021, Magnet Designation, and the U.S. Department of Health and Human Services Gold Medal of Honor, highlighting its commitment to high-quality care and patient satisfaction.